Company Profiles

driven by the PitchBook Platform

Imaxio

Description

Provider of a pipeline of vaccines designed to treat human leptospirosis. The company's marketed, clinical-stage and preclinical-stage products are based on an antigen re-engineering platform to improve immunogenicity, as well as to develop more effective vaccines and immunotherapies, enabling patients to improve the immune response on immunogenic antigens.

2000

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$760k

Latest Deal Amount

$7.36M

Total Amount Raised

Description

Provider of a pipeline of vaccines designed to treat human leptospirosis. The company's marketed, clinical-stage and preclinical-stage products are based on an antigen re-engineering platform to improve immunogenicity, as well as to develop more effective vaccines and immunotherapies, enabling patients to improve the immune response on immunogenic antigens.

Website:

www.imaxio.com

Formerly Known As

Avidis, Diagnogene

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

99, rue de Gerland 69007 LyonFrance +33 (0)4 37 65 55 00
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Imaxio's full profile, request a free trial.

Imaxio Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Imaxio Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
European UnionGovernment000 0000000 0000
L'Agence Nationale de la RechercheCorporation000 0000000 0000
Pradeyrol DeveloppementCorporationMinority000 0000000 0000
European Union Government
L'Agence Nationale de la Recherche Corporation
Pradeyrol Developpement Corporation

Imaxio Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Alexandre Le VertChief Executive Officer
Sylvain LandonChief Financial Officer
Fergal HillChief Scientific Officer & Scientific Advisory Board Member
Valerie Huertas-FoulonDirector of Pharmaceutical Affairs
Florence Nicolas Ph.DDirector of Preclinical Development
Alexandre Le Vert Chief Executive Officer
Sylvain Landon Chief Financial Officer
Fergal Hill Chief Scientific Officer & Scientific Advisory Board Member
Valerie Huertas-Foulon Director of Pharmaceutical Affairs
Florence Nicolas Ph.D Director of Preclinical Development

Imaxio Board Members (2)

NameRepresentingRoleSinceContact
Info
Christian Pradeyrol MDSelfChairman000 0000
Fergal HillImaxioChief Scientific Officer & Scientific Advisory Board Member000 0000
Christian Pradeyrol MD Chairman Self
Fergal Hill Chief Scientific Officer & Scientific Advisory Board Member Imaxio
Request full access to PitchBook